George Decou v. Takeda Pharmaceuticals America, Inc.

SETTLED

Trial
08/27/15 – 10/06/15

Play button overlay
Play button overlay

Summary

A Nevada state court judge overseeing a potentially $2 billion jury trial over the alleged bladder cancer risks of Takeda Pharmaceutical Co Ltd.’s blockbuster diabetes drug Actos announced Wednesday that the pharmaceutical company and two plaintiffs had tentatively resolved their claims, likely ending a trial that began in August and was expected to continue for weeks.

Click here for more in-depth coverage via the CVN News Blog.

Outcome

Settled

Sessions

AM Session
Openings
3 Chapters
PM Session
Openings
2 Chapters
AUG
27
AM Session
Openings
3 Chapters
AUG
28
AM Session
Not in Session
0 Chapters
SEP
1
AM Session
Plaintiff Witness(es)
2 Chapters
SEP
3
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
7
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
23
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
SEP
24
AM Session
Plaintiff Witness(es)
2 Chapters
PM Session
Not in Session
0 Chapters
SEP
25
AM Session
Not in Session
0 Chapters
PM Session
Not in Session
0 Chapters
OCT
2
AM Session
Defense Witness(es)
0 Chapters
PM Session
Defense Witness(es)
0 Chapters
OCT
7

Recording Disclaimer: This proceeding was recorded in full.

Suggest a Trial

Want to see a trial that you don't see in our list of upcoming trials?

Suggest a Case

CVN Essentials

The most important and informative moments of each trial

CVN Essentials

Video Library

Unlimited access to thousands of hours of past coverage of high stakes civil litigation

Video Library

  • Follow Us
  • Contact Us
  • 3901 Roswell Road
  • Suite 302
  • Marietta, GA 30062
  • 877-838-9067

Copyright 2017 Courtroom Connect.